Monday June 26th 2017

Archive for May, 2017

Minocycline Might Help Prevent Progression to Multiple Sclerosis (FREE)

Minocycline Might Help Prevent Progression to Multiple Sclerosis (FREE)

By the Editors The antibiotic minocycline might help prevent progression to multiple sclerosis in patients with an isolated demyelinating event, a New England Journal of … (Source: Physician's First Watch current issue) [Read More]

Acne antibiotic delays development of multiple sclerosis in small trial

Acne antibiotic delays development of multiple sclerosis in small trial

(Reuters Health) - An inexpensive antibiotic used to fight acne appears to delay the development of multiple sclerosis in people in the earliest stage of the crippling disease, according to a Canadian study. (Source: Reuters: Health)MedWorm Message: Have you tried our new [Read More]

Common acne medicine reduces risk of multiple sclerosis, Calgary researchers find

Common acne medicine reduces risk of multiple sclerosis, Calgary researchers find

Millions of people already take minocycline to treat acne, but University of Calgary researchers have found the inexpensive antibiotic also helps to control multiple sclerosis. (Source: CBC | Health) [Read More]

 Page 1 of 32  1  2  3  4  5 » ...  Last » 

Latest Topics

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

BACKGROUND: In people with Multiple Sclerosis (pwMS), balance assessment is essential in estimating the risk of falls, [Read More]

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

The European Medicines Agency ’ s Committee for Medicinal Products for Human Use recommends approval of cladribine to [Read More]

Germany’s Merck gets EU backing for oral MS drug

Germany’s Merck gets EU backing for oral MS drug

FRANKFURT (Reuters) - Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral [Read More]

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

Roche announced today that new post-hoc analyses from the OCREVUS ™ (ocrelizumab) Phase III clinical trial programme [Read More]

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]